NS-100

N/A

Report date: 2023/02/26 21:03:54

Base Information

Drug NameNS-100
Drug Alias NameNS-100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionNeuropeptides modulators
TargetsNeuropeptides
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuracle Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuracle Science Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A